PEP (Post-Exposure Prophylaxis) – Dolutegravir + Tenofovir + Emtricitabine
PEP is an emergency HIV prevention treatment taken after possible exposure, combining dolutegravir, tenofovir, and emtricitabine for rapid protection.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Post-Exposure Prophylaxis (PEP) is a short-term treatment designed to prevent HIV infection after a potential exposure. The most effective regimen includes dolutegravir (an integrase inhibitor) plus tenofovir and emtricitabine (antiretroviral drugs).
PEP must be started within 72 hours of exposure — the sooner, the better — and continued for 28 days.
It works by blocking the virus from multiplying and spreading in the body’s immune cells.
PEP is commonly prescribed after unprotected sex, needle accidents, or occupational exposure.
Side effects may include nausea or fatigue, but they usually subside after completion.
PEP is a life-saving emergency measure and should always be prescribed and monitored by a healthcare professional.
Be the first to review “PEP (Post-Exposure Prophylaxis) – Dolutegravir + Tenofovir + Emtricitabine”
Related products
Triumeq (Dolutegravir/Abacavir/Lamivudine)
Original price was: $3,800.$3,600Current price is: $3,600.
$492Symtuza (Darunavir/Cobicistat/Emtricitabine/TAF)
Original price was: $4,200.$4,000Current price is: $4,000.Atripla (Efavirenz/Emtricitabine/TDF)
Original price was: $3,200.$3,000Current price is: $3,000.- Original price was: $9.$8.55Current price is: $8.55.
Reviews
There are no reviews yet.